Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

True expertise is built slowly, through years of dedicated study, self-questioning, and experimentation. The quiet experts – ...

Significant regulatory news last week included the US Food and Drug Administration (FDA) granting approval for Zevra ...